Sabra Health Care REIT, Inc. (SBRA) Stock

Sabra Health Care REIT, Inc. (SBRA) is a Real Estate stock trading at $20.39 (as of 2026-08-21), with a market capitalization of $5.21B and a trailing P/E of 79.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Sabra Health Care REIT, Inc. invests in real estate properties held for investment, including skilled nursing/transitional care facilities, senior housing communities (leased or managed by third parties), behavioral health facilities, and specialty hospitals and other facilities. The portfolio spans the United States and Canada.

Understand Sabra Health Care REIT, Inc.: how it makes money

Sabra Health Care REIT, Inc. owns and operates a portfolio of healthcare properties, generating revenue primarily from resident fees and service revenue and from rental and related revenues.

Sabra’s profit engine is the recurring revenue it collects from its property portfolio, primarily through resident fees and service revenue plus rental and related revenues.

Revenue by segment (latest quarter)
Resident Fees$0.1B
Rental & Related$0.1B

Business quality (Solid): Clear, investor-relevant revenue stream breakdown is provided, but the dataset does not include occupancy, pricing, or other per-property operating metrics, so the forward performance drivers are harder to quantify from these facts alone.

Valuation: At 31× earnings, SBRA trades 8% below the Trading average (34×). Note: one-time items can distort reported P/E.

Bull case

  • Recurring revenue streams: Revenue is split across two major lines, Resident Fees and Service Revenue (0.12B) and Rental and Related Revenues (0.1B), linking results to how the underlying healthcare operations generate fees and how leased components generate rent.
  • Broad healthcare property mix: Sabra’s investment portfolio includes multiple property types, including Skilled Nursing/Transitional Care facilities, Senior Housing communities (both leased and managed), Behavioral Health facilities, and Specialty Hospitals and Other facilities (416 properties as of March 31, 2022).

Bear case

  • Sensitivity to healthcare property performance: Because revenue is driven by resident fees and services and by rental and related revenues, adverse conditions affecting healthcare operations or leased property economics could pressure results.
  • Limited operating detail in provided data: The provided facts include revenue stream totals and operating margin for the latest period, but do not include key operating measures like occupancy or per-resident/per-room metrics, limiting visibility into what is driving quarter-to-quarter changes.
Valuation — source: SEC EDGAR (first-party)
Price$20.39
Market Cap$5.21B
P/E Ratio79.6
EV / EBITDA28.2
Price / Book1.89
Price / Sales6.06
DCF Value (model)$28.60
DCF Upside vs Price40.3%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$774.63M
Net Margin20.1%
Revenue Growth (YoY)24.7%
EPS Growth (YoY)-135.7%
Valuation vs Sector & Industry
Stock P/E79.6
Sector P/E (Real Estate)27.2
Industry P/E (Trading)35.3
vs Sector192.9%
vs Industry125.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($751.86M)
Institutional Holders Tracked10
Congressional Trades (recent)4
Company
SectorReal Estate
IndustryTrading
CEORichard K. Matros
Employees50
CountryUS
IPO Date2002-04-02

Related Companies (Business model: Equity REIT (Real Estate Investment Trust); 8 closest by market cap; US-domiciled)

  • Starwood Property Trust, Inc. (STWD)
  • Rithm Capital Corp. (RITM)
  • Outfront Media Inc. (OUT)
  • Kite Realty Group Trust (KRG)
  • Phillips Edison & Company, Inc. (PECO)
  • Cousins Properties Incorporated (CUZ)
  • EPR Properties (EPR)
  • Tanger Inc. (SKT)
SBRA earnings history · SBRA institutional & insider holders · SBRA KPIs & operating metrics · SBRA financials · SBRA investor presentations & press releases · SBRA SEC filings · SBRA peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.